Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Choice of baseline in parallel thorough QT studies.

× No keyword cloud information.

14 in total

1. Shortening of the QT interval after food can be used to demonstrate assay sensitivity in thorough QT studies.

Authors: Jorg Taubel; Alex H Wong; Asif Naseem; Georg Ferber; A John Camm
Journal: J Clin Pharmacol Date: 2011-11-08 Impact factor: 3.126

2. Comparison of statistical models adjusting for baseline in the analysis of parallel-group thorough QT/QTc studies.

Authors: Guowen Gordon Sun; Hui Quan; Robert Kringle; Zhaoling Meng
Journal: J Biopharm Stat Date: 2012 Impact factor: 1.051

3. Use of the average baseline versus the time-matched baseline in parallel group thorough QT/QTc studies.

Authors: Zhaoling Meng; Hui Quan; Li Fan; Robert Kringle; Gordon Sun
Journal: J Biopharm Stat Date: 2010-05 Impact factor: 1.051

4. Systematic decrements in QTc between the first and second day of contiguous daily ECG recordings under controlled conditions.

Authors: Charles M Beasley; Charles Benson; Jessie Q Xia; S Stanley Young; Harry Haber; Malcolm I Mitchell; Corina Loghin
Journal: Pacing Clin Electrophysiol Date: 2011-04-28 Impact factor: 1.976

5. An efficient and robust analysis of covariance model for baseline adjustment in parallel-group thorough QT/QTc studies.

Authors: Kaifeng Lu
Journal: Stat Med Date: 2012-09-19 Impact factor: 2.373

6. Circadian rhythm of the corrected QT interval: impact of different heart rate correction models.

Authors: Peter Smetana; Velislav Batchvarov; Katerina Hnatkova; A John Camm; Marek Malik
Journal: Pacing Clin Electrophysiol Date: 2003-01 Impact factor: 1.976

7. Effect of nalmefene 20 and 80 mg on the corrected QT interval and T-wave morphology: a randomized, double-blind, parallel-group, placebo- and moxifloxacin-controlled, single-centre study.

Authors: Jørgen Matz; Claus Graff; Petri J Vainio; Antero Kallio; Astrid Maria Højer; Johannes J Struijk; Jørgen K Kanters; Mads P Andersen; Egon Toft
Journal: Clin Drug Investig Date: 2011-11-01 Impact factor: 2.859

Review 1. Drug-drug interactions and QT prolongation as a commonly assessed cardiac effect - comprehensive overview of clinical trials.

Authors: Barbara Wiśniowska; Zofia Tylutki; Gabriela Wyszogrodzka; Sebastian Polak
Journal: BMC Pharmacol Toxicol Date: 2016-03-10 Impact factor: 2.483

1 in total

Choice of baseline in parallel thorough QT studies.